Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Burden of Hospitalizations Due to Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV + PTLD) in Patients Who Failed First Line Rituximab or Rituximab Plus Chemotherapy Following Solid Organ Transplant (Post-SOT): A Retrospective Chart Review Study of German PTLD Registry

Heiner Zimmermann, MD, Hairong Xu, MD PhD, Arie Barlev, PharmD, Yang Zhang, PhD, Dhanalakshmi Thirumalai, Crystal Watson, MS, Ralf Ulrich Trappe, MD

Blood (2019) 134 (Supplement_1): 65.

https://doi.org/10.1182/blood-2019-124583

Published: 2019

Journal Articles

Treatment Patterns for Patients with Post-Transplant Lymphoproliferative Disorder Who Fail Rituximab after Allogeneic Hematopoietic Stem Cell Transplantation: Findings from a Systematic Literature Review

Hairong Xu, MD PhD, Crystal Watson, MS, Shan Ashton Garib, MA, Anna Forsythe, PharmD, MSc, MBA, Arie Barlev, PharmD

Blood (2018) 132 (Supplement 1): 4777.

https://doi.org/10.1182/blood-2018-99-113593

Published: 2018

Journal Articles

A Systematic Literature Review of Real-World Evidence in Post-Transplant Lymphoproliferative Disorder

Hairong Xu, MD PhD, Anna Forsythe, PharmD, MSc, MBA, Arie Barlev, PharmD, Nazia Rashid, PharmD, Crystal Watson, MS

Blood (2018) 132 (Supplement 1): 5839.

https://doi.org/10.1182/blood-2018-99-113583

Published: 2018

Journal Articles

Risk of Patients Developing Post-Transplant Lymphoproliferative Disorder within the First Year after an Allogeneic Hemopoietic Stem Cell Transplant, 2011 to 2016: A US Claims Database Analysis

Arie Barlev, PharmD, Hairong Xu, MD PhD, Nicole Fulcher, MA, Crystal Watson, MS, Ila Sruti, MPH, Akshay Sudhindra, MD

Blood (2018) 132 (Supplement 1): 5840.

https://doi.org/10.1182/blood-2018-99-113598

Published: 2018

Journal Articles

Younger Patients Are Impacted By Post-Transplant Lymphoproliferative Disorder: Findings from a Systematic Literature Review of Real-World Evidence

Crystal Watson, MS, Hairong Xu, MD PhD, Anna Forsythe, PharmD, MSc, MBA, Shan Ashton Garib, MA, Arie Barlev, PharmD

Blood (2018) 132 (Supplement 1): 5841.

https://doi.org/10.1182/blood-2018-99-113622

Published: 2018

Journal Articles

A Risk Prediction Model for Severe Chemotherapy-Induced Anemia in Breast Cancer Patients

Chun Chao, PhD, Lanfang Xu, MSc, Leila Family, PhD MPH, Hairong Xu, MD PhD

Blood (2016) 128 (22): 2399.

https://doi.org/10.1182/blood.V128.22.2399.2399

Published: 2016

Journal Articles

A Study of Symptom Burdens Related to Chemotherapy-Induced Anemia in Patients Diagnosed with Breast Cancer, Lung Cancer and Non-Hodgkin Lymphoma

Chun Chao, PhD, Leila Family, PhD MPH, Kimberly Cannavale, MSc, Andrew Pourmoussa, MD, Lanfang Xu, MSc, Mehta Bhakti, MD, Hairong Xu, MD PhD

Blood (2016) 128 (22): 5980.

https://doi.org/10.1182/blood.V128.22.5980.5980

Published: 2016

Journal Articles

Efficacy and Safety of Darbepoetin Alfa (DA) in Patients with Myelodysplastic Syndromes (MDS): A Systematic Review and Meta-Analysis

Sophie Park, MD PhD, Pierre Fenaux, MD PhD, Peter Greenberg, MD, Bhakti Mehta, MD MPH, Fiona Callaghan, PhD, Christopher Kim, PhD MPH, Dianne Tomita, PhD, Hairong Xu, MD PhD

Blood (2015) 126 (23): 5236.

https://doi.org/10.1182/blood.V126.23.5236.5236

Published: 2015

Journal Articles

Incidence of Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified As High-Risk in Guidelines for Myeloid Growth Factor Use: Importance of “Risk Factor Stacking”

Derek Weycker, PhD, Xiaoyan Li, PhD, Rich Barron, M.S., Hongsheng Wu, PhD, Phuong Khanh Morrow, MD, Hairong Xu, MD, PhD, Maureen Reiner, M.S., Jacob Garcia, MD, Shivani Mhatre, M.S., Gary H. Lyman, MD MPH

Blood (2014) 124 (21): 4824.

https://doi.org/10.1182/blood.V124.21.4824.4824

Published: 2014

Journal Articles

Trends in Anemia Treatment Among Patients with Non-Myeloid Malignancies Treated with Chemotherapy

Chun Chao, PhD, Lanfang Xu, MS, Olivia Sattayapiwat, MS, John H Page, MD ScD, Kimberly Cannavale, Roberto Rodriguez, MD, Chet Bohac, Hairong Xu, MD, PhD

Blood (2014) 124 (21): 6007.

https://doi.org/10.1182/blood.V124.21.6007.6007

Published: 2014

Journal Articles

Incidence of Chemotherapy Induced Anemia in Patients Diagnosed with Solid Tumors

Hairong Xu, MD, PhD, Lanfang Xu, MS, John H Page, MD ScD, Olivia Sattayapiwat, MS, Roberto Rodriguez, MD, Chun Chao, PhD

Blood (2014) 124 (21): 4822.

https://doi.org/10.1182/blood.V124.21.4822.4822

Published: 2014

NARROW

Burden of Hospitalizations Due to Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV + PTLD) in Patients Who Failed First Line Rituximab or Rituximab Plus Chemotherapy Following Solid Organ Transplant (Post-SOT): A Retrospective Chart Review Study of German PTLD Registry

Treatment Patterns for Patients with Post-Transplant Lymphoproliferative Disorder Who Fail Rituximab after Allogeneic Hematopoietic Stem Cell Transplantation: Findings from a Systematic Literature Review

A Systematic Literature Review of Real-World Evidence in Post-Transplant Lymphoproliferative Disorder

Risk of Patients Developing Post-Transplant Lymphoproliferative Disorder within the First Year after an Allogeneic Hemopoietic Stem Cell Transplant, 2011 to 2016: A US Claims Database Analysis

Younger Patients Are Impacted By Post-Transplant Lymphoproliferative Disorder: Findings from a Systematic Literature Review of Real-World Evidence

A Risk Prediction Model for Severe Chemotherapy-Induced Anemia in Breast Cancer Patients

A Study of Symptom Burdens Related to Chemotherapy-Induced Anemia in Patients Diagnosed with Breast Cancer, Lung Cancer and Non-Hodgkin Lymphoma

Efficacy and Safety of Darbepoetin Alfa (DA) in Patients with Myelodysplastic Syndromes (MDS): A Systematic Review and Meta-Analysis

Incidence of Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified As High-Risk in Guidelines for Myeloid Growth Factor Use: Importance of “Risk Factor Stacking”

Trends in Anemia Treatment Among Patients with Non-Myeloid Malignancies Treated with Chemotherapy

Incidence of Chemotherapy Induced Anemia in Patients Diagnosed with Solid Tumors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only